Novartis says announces US tariffs should have no impact on the company

  • So far, Trump's latest tariffs are not having much of an impact on markets
Novartis

The initial reaction at the open in Europe today saw pharmaceutical stocks fall en masse. That after the announcement by Trump here earlier in the day. But as we move along the session, those shares have now pared losses across the board and broader market sentiment has largely shrugged off any tariffs concern.

Top Brokers

Sponsored

General Risk Warning
investingLive Premium
Telegram Community
Gain Access